Ananda Developments - Management accounts for quarter ended 31 July 2024
RNS
Latest announcements
Announcement summary
Ananda Developments - Management accounts for quarter ended 31 July 2024
Ananda Developments Plc (AQUIS: ANA), a life sciences company focused on the research and clinical development of CBD-based therapies for a range of complex inflammatory pain conditions, announces its unaudited Company management statements for the quarter ended 31 July 2024.
Ask a question
Your question will be sent privately to Ananda Pharma. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Ananda Pharma a question about this announcement.